Affiliation:
1. Faculty of Medical Sciences in Katowice, Medical University of Silesia, 40-752 Katowice, Poland
2. Department of Medical and Health Sciences, Collegium Medicum—Faculty of Medicine, WSB University, 41-300 Dąbrowa Górnicza, Poland
Abstract
Janus kinase inhibitors, also known as JAK inhibitors, JAKinibs or JAKi, are a new group of disease-modifying drugs. They work by inhibiting enzymes involved in the transmission of information from receptors located in the cell membrane to the cell interior, specifically to the cell nucleus, thus disrupting the JAK-STAT pathway. This pathway plays a role in key cellular processes such as the immune response and cell growth. This feature is used in the treatment of patients with rheumatological, gastroenterological and hematological diseases. Recently, it has been discovered that JAK-STAT pathway inhibitors also show therapeutic potential against dermatological diseases such as atopic dermatitis, psoriasis, alopecia areata and acquired vitiligo. Studies are underway to use them in the treatment of several other dermatoses. Janus kinase inhibitors represent a promising class of drugs for the treatment of skin diseases refractory to conventional therapy. The purpose of this review is to summarize the latest knowledge on the use of JAKi in dermatological treatment.
Subject
Chemistry (miscellaneous),Analytical Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Molecular Medicine,Drug Discovery,Pharmaceutical Science
Reference96 articles.
1. Emerging Topical and Systemic JAK Inhibitors in Dermatology;Solimani;Front. Immunol.,2019
2. Immune response patterns in non-communicable inflammatory skin diseases;Eyerich;J. Eur. Acad. Dermatol. Venereol.,2018
3. Cutaneous immunology: Basics and new concepts;Yazdi;Semin. Immunopathol.,2016
4. Janus Kinase and Tyrosine Kinase Inhibitors in Dermatology: A Review of Their Utilization, Safety Profile and Future Applications;Shalabi;Skin Ther. Lett.,2022
5. JAK-STAT inhibitors in Immune mediated diseases: An Overview;Shah;Indian J. Dermatol. Venereol. Leprol.,2023
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献